probenecid has been researched along with Colonic Neoplasms in 3 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, S | 1 |
| Shikano, N | 1 |
| Kotani, T | 1 |
| Ogura, M | 1 |
| Nishii, R | 1 |
| Yoshimoto, M | 1 |
| Yamaguchi, N | 1 |
| Iwamura, Y | 1 |
| Kubota, N | 1 |
| Ishikawa, N | 1 |
| Kawai, K | 1 |
| Kondrashin, A | 1 |
| Nesterova, M | 1 |
| Cho-Chung, YS | 1 |
| Gupta, E | 1 |
| Vyas, V | 1 |
| Ahmed, F | 1 |
| Sinko, P | 1 |
| Cook, T | 1 |
| Rubin, E | 1 |
3 other studies available for probenecid and Colonic Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics of 3-[125I]iodo-alpha-methyl-L-tyrosine, a tumor imaging agent, after probenecid loading in mice implanted with colon cancer DLD-1 cells.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Kidney; Male; Metabolic Clearance Rate; Methyltyrosine | 2007 |
Cyclic adenosine 3':5'-monophosphate-dependent protein kinase on the external surface of LS-174T human colon carcinoma cells.
Topics: Azides; Binding Sites; Catalysis; Cell Membrane; Colforsin; Colonic Neoplasms; Cyclic AMP; Cyclic AM | 1999 |
Pharmacokinetics of orally administered camptothecins.
Topics: Administration, Oral; Anion Transport Proteins; Antineoplastic Agents, Phytogenic; Biological Transp | 2000 |